My Profile

Search abstracts

Lewis Sheiner


2017
Budapest, Hungary



2016
Lisboa, Portugal

2015
Hersonissos, Crete, Greece

2014
Alicante, Spain

2013
Glasgow, Scotland

2012
Venice, Italy

2011
Athens, Greece

2010
Berlin, Germany

2009
St. Petersburg, Russia

2008
Marseille, France

2007
København, Denmark

2006
Brugge/Bruges, Belgium

2005
Pamplona, Spain

2004
Uppsala, Sweden

2003
Verona, Italy

2002
Paris, France

2001
Basel, Switzerland

2000
Salamanca, Spain

1999
Saintes, France
   Program
   Abstracts


1998
Wuppertal, Germany

1997
Glasgow, Scotland

1996
Sandwich, UK

1995
Frankfurt, Germany

1994
Greenford, UK

1993
Paris, France

1992
Basel, Switzerland

Printable version
Thursday June 17
08:00-08:40 Registration and coffee
08:40-09:00 Welcome and Introduction
Oral session I PK/PD modelling chair: Rik Schoemaker
09:00-09:35 Janet Wade Combining PK and PD data during population PK/PD analysis
09:35-10:00 Mats Karlsson A pharmacodynamic Markov mixed effect model for temazepam effect on sleep
10:00-11:30 Poster and software session I
Oral session II Non-parametric methods chair: Christian Pobel
11:30-12:10 Alain Mallet Non-parametric methods for continuous and binary data variables in population PK/PD
12:10-12:30 Roger Jelliffe Population PK/PD modelling and optimal drug dosage
12:30-14:00 Lunch
Oral session III Trial design chair: France Mentre
14:00-14:35 Byron Jones Constructing optimal designs for fitting pharmacokinetic models
14:35-15:10 Mick Looby Dose-response in early drug development
15:10-15:45 Michel Tod Robust optimal design for population parameters
15:45-16:45 Poster and software session II
Oral session IV Clinical applications chair: Leon Aarons
16:45-17:05 Gilles Freyer Population pharmacokinetic parameters of doxorubicin, ifosfamide and etoposide in small cell lung cancer patients
17:05-17:25 Stephen Dufful Development of a linked pharmacokinetic and pharmacodynamic simulation model for ivabradine in healthy volunteers
17:25-17:45 Sylvie Chabaud Use of a therapeutic model for simulating phase III clinical trials of a new bradycardic agent
17:45-17:55 Pascal Girard PAGE discussion
19:45- open Social event about 5 minutes from hotels by coaches
Friday June 18
Oral session V chair: Pascal Girard
09:00-09:45 Anthony Davison Bootstrap methods
09:45-10:05 Ulrika Wählby Determination of inclusion frequency of false covariate relationships in population modelling
10:05-10:25 Per Olsson Giselskog The use of priors in NONMEM analysis
10:25-11:55 Poster and software session III
Oral session VI chair: Janet Wade
11:55-12:30 Peter Milligan Viagra
12:30-13:05 Barry Jones Pharmacogenetics
13:05-13:25 Niclas Jonsson Quantifying non-standard evidence for drug approval
13:25-13:45 Roberto Gomeni Population analysis (NONMEM) using a concentration-to-event approach to evaluate the propofol anaesthesia induction strategy using a TCI system
13:45-14:00 Closure followed by light lunch